Statistical Methodology for a SMART Design in the Development of Adaptive Treatment Strategies
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The past two decades have brought new pharmacotherapies as well as behavioral therapies to the field of drug-addiction treatment (Carroll & Onken, 2005; Carroll, 2005; Ling & Smith, 2002; Fiellin, Kleber, Trumble-Hejduk, McLellan, & Kosten, 2004). Despite this progress, the treatment of addiction in clinical practice often remains a matter of trial and error. Some reasons for this difficulty are as follows. First, to date, no one treatment has been found that works well for most patients; that is, patients are heterogeneous in response to any specific treatment. Second, as many authors have pointed out (McLellan, 2002; McLellan, Lewis, O’Brien, & Kleber, 2000), addiction is often a chronic condition, with symptoms waxing and waning over time. Third, relapse is common. Therefore, the clinician is faced with, first, finding a sequence of treatments that works initially to stabilize the patient and, next, deciding which types of treatments will prevent relapse in the longer term. To inform this sequential clinical decision making, adaptive treatment strategies, that is, treatment strategies shaped by individual patient characteristics or patient responses to prior treatments, have been proposed (Greenhouse, Stangl, Kupfer, & Prien, 1991; Murphy, 2003, 2005; Murphy, Lynch, Oslin, McKay, & Tenhave, 2006; Murphy, Oslin, Rush, & Zhu, 2007; Lavori & Dawson, 2000; Lavori, Dawson, & Rush, 2000; Dawson & Lavori, 2003). Here is an example of an adaptive treatment strategy for prescription opioid dependence, modeled with modifications after a trial currently in progress within the Clinical Trials Network of the National Institute on Drug Abuse (Weiss, Sharpe, & Ling, 2010). . . . Example . . . . . . First, provide all patients with a 4-week course of buprenorphine/naloxone (Bup/Nx) plus medical management (MM) plus individual drug counseling (IDC) (Fiellin, Pantalon, Schottenfeld, Gordon, & O’Connor, 1999), culminating in a taper of the Bup/Nx. If at any time during these 4 weeks the patient meets the criterion for nonresponse, a second, longer treatment with Bup/Nx (12 weeks) is provided, accompanied by MM and cognitive behavior therapy (CBT). However, if the patient remains abstinent from opioid use during those 4 weeks, that is, responds to initial treatment, provide 12 additional weeks of relapse prevention therapy (RPT). . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622
An experimental design for the development of adaptive treatment strategies
Murphy, S. A. (2005) · Statistics in Medicine · doi:10.1002/sim.2022 · Cited by 746 · cited 3×
“Sample Size Formulae for Question 3 Here, we present the derivation of the sample size formulae N 3a and N 3b for question 3 using results from Murphy (2005).”
MethodCounseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence
Fiellin, D. A., Pantalon, M. V., Chawarski, M. C., Moore, B. A., Sullivan, L. E., O'Connor, P. G., & Schottenfeld, R. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055255 · Cited by 351 · cited 1×
“The simulated data reflect the types of scenarios found in substance-abuse clinical trials (Gandhi et al., 2003; Fiellin et al., 2006; Ling et al., 2005).”
BackgroundDeveloping adaptive treatment strategies in substance abuse research
Murphy, S. A., Lynch, K. G., Oslin, D., McKay, J. R., & TenHave, T. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.09.008 · Cited by 211
Methodologic issues in maintenance therapy clinical trials
Greenhouse, J. B. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280029004 · Cited by 89
Cited by
Almirall, D., Nahum-Shani, I., Sherwood, N. E., & Murphy, S. A. (2014) · Translational Behavioral Medicine · doi:10.1007/s13142-014-0265-0 · Cited by 453
Experimental design and primary data analysis methods for comparing adaptive interventions.
Nahum-Shani, I., Qian, M., Almirall, D., Pelham, W. E., Gnagy, B., Fabiano, G. A., Waxmonsky, J. G., Yu, J., & Murphy, S. A. (2012) · Psychological Methods · doi:10.1037/a0029372 · Cited by 298
Chakraborty, B., & Murphy, S. A. (2014) · Annual Review of Statistics and Its Application · doi:10.1146/annurev-statistics-022513-115553 · Cited by 286
Wang, L., Rotnitzky, A., Lin, X., Millikan, R. E., & Thall, P. F. (2012) · Journal of the American Statistical Association · doi:10.1080/01621459.2011.641416 · Cited by 108
Almirall, D., Lizotte, D. J., & Murphy, S. A. (2012) · Journal of the American Statistical Association · doi:10.1080/01621459.2012.665615 · Cited by 19
Metadata
- Authors
- Oetting, A. I., & Levy, J. A.
- Venue
- Causality and Psychopathology
- Publisher
- Oxford University Press
- Published
- 2011-02-03
- OpenAlex
- W3102460569
- Cited by
- 56
- References
- 5
- FWCI
- 12.25
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Statistical Methodology for a SMART Design in the Development of Adaptive Treatment Strategies. https://app.cochat.ai/papers/10.1093/oso/9780199754649.003.0013
- The paper
- Oetting, A. I., & Levy, J. A. (2011). Statistical Methodology for a SMART Design in the Development of Adaptive Treatment Strategies. Causality and Psychopathology. https://doi.org/10.1093/oso/9780199754649.003.0013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.